Accenture Secures Task Order for Military Pharma Supply Chain Assessment
Accenture Federal Services has received a sole-source task order from the Defense Health Agency to evaluate domestic production proposals for essential military medications. This initiative addresses supply chain vulnerabilities, as most active pharmaceutical ingredients for key combat drugs are sourced internationally.

The Defense Health Agency (DHA) has awarded Accenture Federal Services a sole-source task order to evaluate domestic manufacturing proposals for military-essential medications, due to urgent supply chain vulnerabilities. The 10-week assessment will include reviewing proposals for strengths and weaknesses, testing manufacturing feasibility, and developing independent cost models for active pharmaceutical ingredients (APIs).
The DHA bypassed competitive bidding to expedite the process, citing that other vendors would require significant ramp-up time. The findings will inform decisions on whether to proceed, modify, or pause the proposals. This project is part of a broader initiative to enhance pharmaceutical supply chain security and reduce reliance on foreign sources.




Comments